doi: 10.1007/s10072-019-03863-x 182 ChenSLiuARAnFMYaoWBGaoXD
Yes, and it is strongly encouraged
Mehan S, Bhalla S, Siddiqui EM, Sharma N, Shandilya A, Khan A (2022) Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration
In the phase 2b trial, however, the reductions in glycated hemoglobin and body weight in participants treated with NNC0090-2746 were similar to those in the group treated with liraglutide (76), and no phase 3 trial of NNC0090-2746 has been reported yet
If youve been frustrated with weight loss in the past and think hormonal imbalances might be the reason, its time to take a different approach
In our practice, constipation is one of the most consistently reported problems on GLP-1 therapy, particularly in the first weeks of a new dose